Chemgenex Pharmaceuticals Overview

  • Year Founded
  • 1958

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 19

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $227M

Chemgenex Pharmaceuticals General Information

Description

Developer of therapeutics in the areas of oncology, diabetes, obesity and depression. The company develops small molecules with new mechanisms of action to treat malignancies with significant unmet medical needs.

Contact Information

Formerly Known As
AutogenChemGenex Pharmaceuticals, Autogen Ltd
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Level 4 199 Moorabool St
  • P.O. Boc 1069
  • Geelong, Victoria 3220
  • Australia
+61 (03)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Vertical(s)
Corporate Office
  • Level 4 199 Moorabool St
  • P.O. Boc 1069
  • Geelong, Victoria 3220
  • Australia
+61 (03)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Chemgenex Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 29-Mar-2011 $227M Completed Generating Revenue
7. PIPE 22-Oct-2010 Completed Generating Revenue
6. PIPE 01-Apr-2009 Completed Generating Revenue
5. PIPE 18-Sep-2008 Completed Generating Revenue
4. PIPE 15-Apr-2007 Completed Generating Revenue
3. PIPE 01-May-2006 Completed Generating Revenue
2. PIPE 01-Jan-2005 $6.29M $10.7M Completed Generating Revenue
1. PIPE 14-Jul-2004 $4.38M $4.38M Completed Generating Revenue
To view Chemgenex Pharmaceuticals’s complete valuation and funding history, request access »

Chemgenex Pharmaceuticals Patents

Chemgenex Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2005095610-A1 Nucleic acid expressed in the hypothalamus or muscle tissue and uses thereof in diagnoses Inactive 31-Mar-2004
WO-2005090378-A1 Ligands of the molecule fit (agt-121) and their pharmaceutical use Inactive 16-Mar-2004
WO-2005074923-A1 Methods and compositions Inactive 03-Feb-2004
WO-2005026358-A1 Polymorphisms in selenoprotein s Inactive 18-Sep-2003
WO-2005026358-A9 Polymorphisms in selenoprotein s Inactive 18-Sep-2003 C07K14/47
To view Chemgenex Pharmaceuticals’s complete patent history, request access »

Chemgenex Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Chemgenex Pharmaceuticals Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Allan Gray Australia Mutual Fund Minority
Alta Partners Venture Capital Minority
GBS Venture Partners Venture Capital Minority
Merck Sante Corporation Minority
QIC Sovereign Wealth Fund Minority
To view Chemgenex Pharmaceuticals’s complete investors history, request access »

Chemgenex Pharmaceuticals Acquisitions (1)

Chemgenex Pharmaceuticals’s most recent deal was a Merger/Acquisition with ChemGenex Therapeutics for . The deal was made on 21-Jun-2004.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
ChemGenex Therapeutics 21-Jun-2004 Merger/Acquisition Drug Discovery
To view Chemgenex Pharmaceuticals’s complete acquisitions history, request access »

Chemgenex Pharmaceuticals FAQs

  • When was Chemgenex Pharmaceuticals founded?

    Chemgenex Pharmaceuticals was founded in 1958.

  • Where is Chemgenex Pharmaceuticals headquartered?

    Chemgenex Pharmaceuticals is headquartered in Geelong, Australia.

  • What is the size of Chemgenex Pharmaceuticals?

    Chemgenex Pharmaceuticals has 19 total employees.

  • What industry is Chemgenex Pharmaceuticals in?

    Chemgenex Pharmaceuticals’s primary industry is Biotechnology.

  • Is Chemgenex Pharmaceuticals a private or public company?

    Chemgenex Pharmaceuticals is a Private company.

  • What is the current valuation of Chemgenex Pharmaceuticals?

    The current valuation of Chemgenex Pharmaceuticals is .

  • What is Chemgenex Pharmaceuticals’s current revenue?

    The current revenue for Chemgenex Pharmaceuticals is .

  • How much funding has Chemgenex Pharmaceuticals raised over time?

    Chemgenex Pharmaceuticals has raised $71M.

  • Who are Chemgenex Pharmaceuticals’s investors?

    Allan Gray Australia, Alta Partners, GBS Venture Partners, Merck Sante, and QIC have invested in Chemgenex Pharmaceuticals.

  • When was Chemgenex Pharmaceuticals acquired?

    Chemgenex Pharmaceuticals was acquired on 29-Mar-2011.

  • Who acquired Chemgenex Pharmaceuticals?

    Chemgenex Pharmaceuticals was acquired by Cephalon.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process